N-アセチルシステインのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global N-acetylcysteine(CAS 616-91-1) Market Insights and Forecast to 2028

• レポートコード：QY2203B00890 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のN-アセチルシステインの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にN-アセチルシステインの世界市場のxxx％を占める「医療グレード N-アセチルシステイン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「パラセタモール過量投与」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のN-アセチルシステインの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのN-アセチルシステイン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのN-アセチルシステイン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 N-アセチルシステインのグローバル主要メーカーには、BASF、WACKER、Cumberland Pharmaceuticals、Zambon、Bioniche Life Sciences、Manus Aktteva Biopharma、Hubei Shengbaolai Biological Technology、Ningbo Create-BIO ENGINEERING、XYS、Hubei Jusheng Technology、Wuhan Grand Hoyo、Wuhan Hezhong Bio-Chemical、Zhangjiagang Huachang Pharmaceutical、Zhangjiagang Shuguang Biological Factory、Donboo Amino Acid、WUXI ENOVO CHEMICAL、Ningbo Zhenhai Haide Amino Acid、Xinyi Hanling Biological Engineering、ZHANGJIAGANG SPECOM BIOCHEMICAL、Wuhan lullaby pharmaceutical chemicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 N-アセチルシステイン市場は、種類と用途によって区分されます。世界のN-アセチルシステイン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 医療グレード N-アセチルシステイン、産業グレード N-アセチルシステイン 【用途別セグメント】 パラセタモール過量投与、溶血療法、腎保護剤、シクロホスファミド、 出血性膀胱炎、微生物性、間質性肺疾患、精神科領域 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - N-アセチルシステイン製品概要 - 種類別市場（医療グレード N-アセチルシステイン、産業グレード N-アセチルシステイン） - 用途別市場（パラセタモール過量投与、溶血療法、腎保護剤、シクロホスファミド、 出血性膀胱炎、微生物性、間質性肺疾患、精神科領域） - 調査の目的 ・エグゼクティブサマリー - 世界のN-アセチルシステイン販売量予測2017-2028 - 世界のN-アセチルシステイン売上予測2017-2028 - N-アセチルシステインの地域別販売量 - N-アセチルシステインの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別N-アセチルシステイン販売量 - 主要メーカー別N-アセチルシステイン売上 - 主要メーカー別N-アセチルシステイン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（医療グレード N-アセチルシステイン、産業グレード N-アセチルシステイン） - N-アセチルシステインの種類別販売量 - N-アセチルシステインの種類別売上 - N-アセチルシステインの種類別価格 ・用途別市場規模（パラセタモール過量投与、溶血療法、腎保護剤、シクロホスファミド、 出血性膀胱炎、微生物性、間質性肺疾患、精神科領域） - N-アセチルシステインの用途別販売量 - N-アセチルシステインの用途別売上 - N-アセチルシステインの用途別価格 ・北米市場 - 北米のN-アセチルシステイン市場規模（種類別、用途別） - 主要国別のN-アセチルシステイン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのN-アセチルシステイン市場規模（種類別、用途別） - 主要国別のN-アセチルシステイン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のN-アセチルシステイン市場規模（種類別、用途別） - 主要国別のN-アセチルシステイン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のN-アセチルシステイン市場規模（種類別、用途別） - 主要国別のN-アセチルシステイン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのN-アセチルシステイン市場規模（種類別、用途別） - 主要国別のN-アセチルシステイン市場規模（トルコ、サウジアラビア） ・企業情報 BASF、WACKER、Cumberland Pharmaceuticals、Zambon、Bioniche Life Sciences、Manus Aktteva Biopharma、Hubei Shengbaolai Biological Technology、Ningbo Create-BIO ENGINEERING、XYS、Hubei Jusheng Technology、Wuhan Grand Hoyo、Wuhan Hezhong Bio-Chemical、Zhangjiagang Huachang Pharmaceutical、Zhangjiagang Shuguang Biological Factory、Donboo Amino Acid、WUXI ENOVO CHEMICAL、Ningbo Zhenhai Haide Amino Acid、Xinyi Hanling Biological Engineering、ZHANGJIAGANG SPECOM BIOCHEMICAL、Wuhan lullaby pharmaceutical chemical ・産業チェーン及び販売チャネル分析 - N-アセチルシステインの産業チェーン分析 - N-アセチルシステインの原材料 - N-アセチルシステインの生産プロセス - N-アセチルシステインの販売及びマーケティング - N-アセチルシステインの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - N-アセチルシステインの産業動向 - N-アセチルシステインのマーケットドライバー - N-アセチルシステインの課題 - N-アセチルシステインの阻害要因 ・主な調査結果

Market Analysis and Insights: Global N-acetylcysteine(CAS 616-91-1) Market
Due to the COVID-19 pandemic, the global N-acetylcysteine(CAS 616-91-1) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Medical Grade N-acetylcysteine accounting for % of the N-acetylcysteine(CAS 616-91-1) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Paracetamol Overdose segment is altered to an % CAGR throughout this forecast period.
China N-acetylcysteine(CAS 616-91-1) market size is valued at US$ million in 2021, while the US and Europe N-acetylcysteine(CAS 616-91-1) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe N-acetylcysteine(CAS 616-91-1) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of N-acetylcysteine(CAS 616-91-1) include BASF, WACKER, Cumberland Pharmaceuticals, Zambon, Bioniche Life Sciences, Manus Aktteva Biopharma, Hubei Shengbaolai Biological Technology, Ningbo Create-BIO ENGINEERING and XYS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the N-acetylcysteine(CAS 616-91-1) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of N-acetylcysteine(CAS 616-91-1) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global N-acetylcysteine(CAS 616-91-1) Scope and Segment
N-acetylcysteine(CAS 616-91-1) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global N-acetylcysteine(CAS 616-91-1) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Medical Grade N-acetylcysteine
Industrial Grade N-acetylcysteine
Segment by Application
Paracetamol Overdose
Mucolytic Therapy
Nephroprotective Agent
Cyclophosphamide-induced Hemorrhagic Cystitis
Microbiological
Interstitial Lung Disease
Psychiatry
By Company
BASF
WACKER
Cumberland Pharmaceuticals
Zambon
Bioniche Life Sciences
Manus Aktteva Biopharma
Hubei Shengbaolai Biological Technology
Ningbo Create-BIO ENGINEERING
XYS
Hubei Jusheng Technology
Wuhan Grand Hoyo
Wuhan Hezhong Bio-Chemical
Zhangjiagang Huachang Pharmaceutical
Zhangjiagang Shuguang Biological Factory
Donboo Amino Acid
WUXI ENOVO CHEMICAL
Ningbo Zhenhai Haide Amino Acid
Xinyi Hanling Biological Engineering
ZHANGJIAGANG SPECOM BIOCHEMICAL
Wuhan lullaby pharmaceutical chemical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 N-acetylcysteine(CAS 616-91-1) Product Introduction
1.2 Market by Type
1.2.1 Global N-acetylcysteine(CAS 616-91-1) Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Medical Grade N-acetylcysteine
1.2.3 Industrial Grade N-acetylcysteine
1.3 Market by Application
1.3.1 Global N-acetylcysteine(CAS 616-91-1) Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Paracetamol Overdose
1.3.3 Mucolytic Therapy
1.3.4 Nephroprotective Agent
1.3.5 Cyclophosphamide-induced Hemorrhagic Cystitis
1.3.6 Microbiological
1.3.7 Interstitial Lung Disease
1.3.8 Psychiatry
1.4 Study Objectives
1.5 Years Considered
2 Global N-acetylcysteine(CAS 616-91-1) Production
2.1 Global N-acetylcysteine(CAS 616-91-1) Production Capacity (2017-2028)
2.2 Global N-acetylcysteine(CAS 616-91-1) Production by Region: 2017 VS 2021 VS 2028
2.3 Global N-acetylcysteine(CAS 616-91-1) Production by Region
2.3.1 Global N-acetylcysteine(CAS 616-91-1) Historic Production by Region (2017-2022)
2.3.2 Global N-acetylcysteine(CAS 616-91-1) Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global N-acetylcysteine(CAS 616-91-1) Sales in Volume & Value Estimates and Forecasts
3.1 Global N-acetylcysteine(CAS 616-91-1) Sales Estimates and Forecasts 2017-2028
3.2 Global N-acetylcysteine(CAS 616-91-1) Revenue Estimates and Forecasts 2017-2028
3.3 Global N-acetylcysteine(CAS 616-91-1) Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global N-acetylcysteine(CAS 616-91-1) Sales by Region
3.4.1 Global N-acetylcysteine(CAS 616-91-1) Sales by Region (2017-2022)
3.4.2 Global Sales N-acetylcysteine(CAS 616-91-1) by Region (2023-2028)
3.5 Global N-acetylcysteine(CAS 616-91-1) Revenue by Region
3.5.1 Global N-acetylcysteine(CAS 616-91-1) Revenue by Region (2017-2022)
3.5.2 Global N-acetylcysteine(CAS 616-91-1) Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global N-acetylcysteine(CAS 616-91-1) Production Capacity by Manufacturers
4.2 Global N-acetylcysteine(CAS 616-91-1) Sales by Manufacturers
4.2.1 Global N-acetylcysteine(CAS 616-91-1) Sales by Manufacturers (2017-2022)
4.2.2 Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of N-acetylcysteine(CAS 616-91-1) in 2021
4.3 Global N-acetylcysteine(CAS 616-91-1) Revenue by Manufacturers
4.3.1 Global N-acetylcysteine(CAS 616-91-1) Revenue by Manufacturers (2017-2022)
4.3.2 Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by N-acetylcysteine(CAS 616-91-1) Revenue in 2021
4.4 Global N-acetylcysteine(CAS 616-91-1) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global N-acetylcysteine(CAS 616-91-1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global N-acetylcysteine(CAS 616-91-1) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global N-acetylcysteine(CAS 616-91-1) Sales by Type
5.1.1 Global N-acetylcysteine(CAS 616-91-1) Historical Sales by Type (2017-2022)
5.1.2 Global N-acetylcysteine(CAS 616-91-1) Forecasted Sales by Type (2023-2028)
5.1.3 Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Type (2017-2028)
5.2 Global N-acetylcysteine(CAS 616-91-1) Revenue by Type
5.2.1 Global N-acetylcysteine(CAS 616-91-1) Historical Revenue by Type (2017-2022)
5.2.2 Global N-acetylcysteine(CAS 616-91-1) Forecasted Revenue by Type (2023-2028)
5.2.3 Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Type (2017-2028)
5.3 Global N-acetylcysteine(CAS 616-91-1) Price by Type
5.3.1 Global N-acetylcysteine(CAS 616-91-1) Price by Type (2017-2022)
5.3.2 Global N-acetylcysteine(CAS 616-91-1) Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global N-acetylcysteine(CAS 616-91-1) Sales by Application
6.1.1 Global N-acetylcysteine(CAS 616-91-1) Historical Sales by Application (2017-2022)
6.1.2 Global N-acetylcysteine(CAS 616-91-1) Forecasted Sales by Application (2023-2028)
6.1.3 Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Application (2017-2028)
6.2 Global N-acetylcysteine(CAS 616-91-1) Revenue by Application
6.2.1 Global N-acetylcysteine(CAS 616-91-1) Historical Revenue by Application (2017-2022)
6.2.2 Global N-acetylcysteine(CAS 616-91-1) Forecasted Revenue by Application (2023-2028)
6.2.3 Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Application (2017-2028)
6.3 Global N-acetylcysteine(CAS 616-91-1) Price by Application
6.3.1 Global N-acetylcysteine(CAS 616-91-1) Price by Application (2017-2022)
6.3.2 Global N-acetylcysteine(CAS 616-91-1) Price Forecast by Application (2023-2028)
7 North America
7.1 North America N-acetylcysteine(CAS 616-91-1) Market Size by Type
7.1.1 North America N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2028)
7.1.2 North America N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2028)
7.2 North America N-acetylcysteine(CAS 616-91-1) Market Size by Application
7.2.1 North America N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2028)
7.2.2 North America N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2028)
7.3 North America N-acetylcysteine(CAS 616-91-1) Sales by Country
7.3.1 North America N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2028)
7.3.2 North America N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe N-acetylcysteine(CAS 616-91-1) Market Size by Type
8.1.1 Europe N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2028)
8.1.2 Europe N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2028)
8.2 Europe N-acetylcysteine(CAS 616-91-1) Market Size by Application
8.2.1 Europe N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2028)
8.2.2 Europe N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2028)
8.3 Europe N-acetylcysteine(CAS 616-91-1) Sales by Country
8.3.1 Europe N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2028)
8.3.2 Europe N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific N-acetylcysteine(CAS 616-91-1) Market Size by Type
9.1.1 Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2028)
9.1.2 Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2028)
9.2 Asia Pacific N-acetylcysteine(CAS 616-91-1) Market Size by Application
9.2.1 Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2028)
9.2.2 Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2028)
9.3 Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Region
9.3.1 Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Region (2017-2028)
9.3.2 Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America N-acetylcysteine(CAS 616-91-1) Market Size by Type
10.1.1 Latin America N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2028)
10.1.2 Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2028)
10.2 Latin America N-acetylcysteine(CAS 616-91-1) Market Size by Application
10.2.1 Latin America N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2028)
10.2.2 Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2028)
10.3 Latin America N-acetylcysteine(CAS 616-91-1) Sales by Country
10.3.1 Latin America N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2028)
10.3.2 Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Market Size by Type
11.1.1 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2028)
11.1.2 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2028)
11.2 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Market Size by Application
11.2.1 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2028)
11.2.2 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2028)
11.3 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Country
11.3.1 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2028)
11.3.2 Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Overview
12.1.3 BASF N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 BASF N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 WACKER
12.2.1 WACKER Corporation Information
12.2.2 WACKER Overview
12.2.3 WACKER N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 WACKER N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 WACKER Recent Developments
12.3 Cumberland Pharmaceuticals
12.3.1 Cumberland Pharmaceuticals Corporation Information
12.3.2 Cumberland Pharmaceuticals Overview
12.3.3 Cumberland Pharmaceuticals N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Cumberland Pharmaceuticals N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Cumberland Pharmaceuticals Recent Developments
12.4 Zambon
12.4.1 Zambon Corporation Information
12.4.2 Zambon Overview
12.4.3 Zambon N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Zambon N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Zambon Recent Developments
12.5 Bioniche Life Sciences
12.5.1 Bioniche Life Sciences Corporation Information
12.5.2 Bioniche Life Sciences Overview
12.5.3 Bioniche Life Sciences N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Bioniche Life Sciences N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Bioniche Life Sciences Recent Developments
12.6 Manus Aktteva Biopharma
12.6.1 Manus Aktteva Biopharma Corporation Information
12.6.2 Manus Aktteva Biopharma Overview
12.6.3 Manus Aktteva Biopharma N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Manus Aktteva Biopharma N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Manus Aktteva Biopharma Recent Developments
12.7 Hubei Shengbaolai Biological Technology
12.7.1 Hubei Shengbaolai Biological Technology Corporation Information
12.7.2 Hubei Shengbaolai Biological Technology Overview
12.7.3 Hubei Shengbaolai Biological Technology N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Hubei Shengbaolai Biological Technology N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Hubei Shengbaolai Biological Technology Recent Developments
12.8 Ningbo Create-BIO ENGINEERING
12.8.1 Ningbo Create-BIO ENGINEERING Corporation Information
12.8.2 Ningbo Create-BIO ENGINEERING Overview
12.8.3 Ningbo Create-BIO ENGINEERING N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Ningbo Create-BIO ENGINEERING N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Ningbo Create-BIO ENGINEERING Recent Developments
12.9 XYS
12.9.1 XYS Corporation Information
12.9.2 XYS Overview
12.9.3 XYS N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 XYS N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 XYS Recent Developments
12.10 Hubei Jusheng Technology
12.10.1 Hubei Jusheng Technology Corporation Information
12.10.2 Hubei Jusheng Technology Overview
12.10.3 Hubei Jusheng Technology N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Hubei Jusheng Technology N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hubei Jusheng Technology Recent Developments
12.11 Wuhan Grand Hoyo
12.11.1 Wuhan Grand Hoyo Corporation Information
12.11.2 Wuhan Grand Hoyo Overview
12.11.3 Wuhan Grand Hoyo N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Wuhan Grand Hoyo N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Wuhan Grand Hoyo Recent Developments
12.12 Wuhan Hezhong Bio-Chemical
12.12.1 Wuhan Hezhong Bio-Chemical Corporation Information
12.12.2 Wuhan Hezhong Bio-Chemical Overview
12.12.3 Wuhan Hezhong Bio-Chemical N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Wuhan Hezhong Bio-Chemical N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Wuhan Hezhong Bio-Chemical Recent Developments
12.13 Zhangjiagang Huachang Pharmaceutical
12.13.1 Zhangjiagang Huachang Pharmaceutical Corporation Information
12.13.2 Zhangjiagang Huachang Pharmaceutical Overview
12.13.3 Zhangjiagang Huachang Pharmaceutical N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Zhangjiagang Huachang Pharmaceutical N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Zhangjiagang Huachang Pharmaceutical Recent Developments
12.14 Zhangjiagang Shuguang Biological Factory
12.14.1 Zhangjiagang Shuguang Biological Factory Corporation Information
12.14.2 Zhangjiagang Shuguang Biological Factory Overview
12.14.3 Zhangjiagang Shuguang Biological Factory N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Zhangjiagang Shuguang Biological Factory N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Zhangjiagang Shuguang Biological Factory Recent Developments
12.15 Donboo Amino Acid
12.15.1 Donboo Amino Acid Corporation Information
12.15.2 Donboo Amino Acid Overview
12.15.3 Donboo Amino Acid N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Donboo Amino Acid N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Donboo Amino Acid Recent Developments
12.16 WUXI ENOVO CHEMICAL
12.16.1 WUXI ENOVO CHEMICAL Corporation Information
12.16.2 WUXI ENOVO CHEMICAL Overview
12.16.3 WUXI ENOVO CHEMICAL N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 WUXI ENOVO CHEMICAL N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 WUXI ENOVO CHEMICAL Recent Developments
12.17 Ningbo Zhenhai Haide Amino Acid
12.17.1 Ningbo Zhenhai Haide Amino Acid Corporation Information
12.17.2 Ningbo Zhenhai Haide Amino Acid Overview
12.17.3 Ningbo Zhenhai Haide Amino Acid N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Ningbo Zhenhai Haide Amino Acid N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Ningbo Zhenhai Haide Amino Acid Recent Developments
12.18 Xinyi Hanling Biological Engineering
12.18.1 Xinyi Hanling Biological Engineering Corporation Information
12.18.2 Xinyi Hanling Biological Engineering Overview
12.18.3 Xinyi Hanling Biological Engineering N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Xinyi Hanling Biological Engineering N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Xinyi Hanling Biological Engineering Recent Developments
12.19 ZHANGJIAGANG SPECOM BIOCHEMICAL
12.19.1 ZHANGJIAGANG SPECOM BIOCHEMICAL Corporation Information
12.19.2 ZHANGJIAGANG SPECOM BIOCHEMICAL Overview
12.19.3 ZHANGJIAGANG SPECOM BIOCHEMICAL N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 ZHANGJIAGANG SPECOM BIOCHEMICAL N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 ZHANGJIAGANG SPECOM BIOCHEMICAL Recent Developments
12.20 Wuhan lullaby pharmaceutical chemical
12.20.1 Wuhan lullaby pharmaceutical chemical Corporation Information
12.20.2 Wuhan lullaby pharmaceutical chemical Overview
12.20.3 Wuhan lullaby pharmaceutical chemical N-acetylcysteine(CAS 616-91-1) Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Wuhan lullaby pharmaceutical chemical N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Wuhan lullaby pharmaceutical chemical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 N-acetylcysteine(CAS 616-91-1) Industry Chain Analysis
13.2 N-acetylcysteine(CAS 616-91-1) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 N-acetylcysteine(CAS 616-91-1) Production Mode & Process
13.4 N-acetylcysteine(CAS 616-91-1) Sales and Marketing
13.4.1 N-acetylcysteine(CAS 616-91-1) Sales Channels
13.4.2 N-acetylcysteine(CAS 616-91-1) Distributors
13.5 N-acetylcysteine(CAS 616-91-1) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 N-acetylcysteine(CAS 616-91-1) Industry Trends
14.2 N-acetylcysteine(CAS 616-91-1) Market Drivers
14.3 N-acetylcysteine(CAS 616-91-1) Market Challenges
14.4 N-acetylcysteine(CAS 616-91-1) Market Restraints
15 Key Finding in The Global N-acetylcysteine(CAS 616-91-1) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global N-acetylcysteine(CAS 616-91-1) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Medical Grade N-acetylcysteine
Table 3. Major Manufacturers of Industrial Grade N-acetylcysteine
Table 4. Global N-acetylcysteine(CAS 616-91-1) Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global N-acetylcysteine(CAS 616-91-1) Production by Region: 2017 VS 2021 VS 2028 (MT)
Table 6. Global N-acetylcysteine(CAS 616-91-1) Production by Region (2017-2022) & (MT)
Table 7. Global N-acetylcysteine(CAS 616-91-1) Production Market Share by Region (2017-2022)
Table 8. Global N-acetylcysteine(CAS 616-91-1) Production by Region (2023-2028) & (MT)
Table 9. Global N-acetylcysteine(CAS 616-91-1) Production Market Share by Region (2023-2028)
Table 10. Global N-acetylcysteine(CAS 616-91-1) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global N-acetylcysteine(CAS 616-91-1) Sales by Region (2017-2022) & (MT)
Table 12. Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Region (2017-2022)
Table 13. Global N-acetylcysteine(CAS 616-91-1) Sales by Region (2023-2028) & (MT)
Table 14. Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Region (2023-2028)
Table 15. Global N-acetylcysteine(CAS 616-91-1) Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Region (2017-2022)
Table 17. Global N-acetylcysteine(CAS 616-91-1) Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Region (2023-2028)
Table 19. Global N-acetylcysteine(CAS 616-91-1) Production Capacity by Manufacturers (2017-2022) & (MT)
Table 20. Global N-acetylcysteine(CAS 616-91-1) Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global N-acetylcysteine(CAS 616-91-1) Sales by Manufacturers (2017-2022) & (MT)
Table 22. Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Manufacturers (2017-2022)
Table 23. Global N-acetylcysteine(CAS 616-91-1) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global N-acetylcysteine(CAS 616-91-1) Revenue Share by Manufacturers (2017-2022)
Table 25. N-acetylcysteine(CAS 616-91-1) Price by Manufacturers 2017-2022 (USD/MT)
Table 26. Global N-acetylcysteine(CAS 616-91-1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global N-acetylcysteine(CAS 616-91-1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in N-acetylcysteine(CAS 616-91-1) as of 2021)
Table 28. N-acetylcysteine(CAS 616-91-1) Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers N-acetylcysteine(CAS 616-91-1) Product Offered
Table 30. Date of Manufacturers Enter into N-acetylcysteine(CAS 616-91-1) Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2022) & (MT)
Table 33. Global N-acetylcysteine(CAS 616-91-1) Sales by Type (2023-2028) & (MT)
Table 34. Global N-acetylcysteine(CAS 616-91-1) Sales Share by Type (2017-2022)
Table 35. Global N-acetylcysteine(CAS 616-91-1) Sales Share by Type (2023-2028)
Table 36. Global N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global N-acetylcysteine(CAS 616-91-1) Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global N-acetylcysteine(CAS 616-91-1) Revenue Share by Type (2017-2022)
Table 39. Global N-acetylcysteine(CAS 616-91-1) Revenue Share by Type (2023-2028)
Table 40. N-acetylcysteine(CAS 616-91-1) Price by Type (2017-2022) & (USD/MT)
Table 41. Global N-acetylcysteine(CAS 616-91-1) Price Forecast by Type (2023-2028) & (USD/MT)
Table 42. Global N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2022) & (MT)
Table 43. Global N-acetylcysteine(CAS 616-91-1) Sales by Application (2023-2028) & (MT)
Table 44. Global N-acetylcysteine(CAS 616-91-1) Sales Share by Application (2017-2022)
Table 45. Global N-acetylcysteine(CAS 616-91-1) Sales Share by Application (2023-2028)
Table 46. Global N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global N-acetylcysteine(CAS 616-91-1) Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global N-acetylcysteine(CAS 616-91-1) Revenue Share by Application (2017-2022)
Table 49. Global N-acetylcysteine(CAS 616-91-1) Revenue Share by Application (2023-2028)
Table 50. N-acetylcysteine(CAS 616-91-1) Price by Application (2017-2022) & (USD/MT)
Table 51. Global N-acetylcysteine(CAS 616-91-1) Price Forecast by Application (2023-2028) & (USD/MT)
Table 52. North America N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2022) & (MT)
Table 53. North America N-acetylcysteine(CAS 616-91-1) Sales by Type (2023-2028) & (MT)
Table 54. North America N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America N-acetylcysteine(CAS 616-91-1) Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2022) & (MT)
Table 57. North America N-acetylcysteine(CAS 616-91-1) Sales by Application (2023-2028) & (MT)
Table 58. North America N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America N-acetylcysteine(CAS 616-91-1) Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2022) & (MT)
Table 61. North America N-acetylcysteine(CAS 616-91-1) Sales by Country (2023-2028) & (MT)
Table 62. North America N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America N-acetylcysteine(CAS 616-91-1) Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2022) & (MT)
Table 65. Europe N-acetylcysteine(CAS 616-91-1) Sales by Type (2023-2028) & (MT)
Table 66. Europe N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe N-acetylcysteine(CAS 616-91-1) Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2022) & (MT)
Table 69. Europe N-acetylcysteine(CAS 616-91-1) Sales by Application (2023-2028) & (MT)
Table 70. Europe N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe N-acetylcysteine(CAS 616-91-1) Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2022) & (MT)
Table 73. Europe N-acetylcysteine(CAS 616-91-1) Sales by Country (2023-2028) & (MT)
Table 74. Europe N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe N-acetylcysteine(CAS 616-91-1) Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2022) & (MT)
Table 77. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Type (2023-2028) & (MT)
Table 78. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2022) & (MT)
Table 81. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Application (2023-2028) & (MT)
Table 82. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Region (2017-2022) & (MT)
Table 85. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales by Region (2023-2028) & (MT)
Table 86. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2022) & (MT)
Table 89. Latin America N-acetylcysteine(CAS 616-91-1) Sales by Type (2023-2028) & (MT)
Table 90. Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2022) & (MT)
Table 93. Latin America N-acetylcysteine(CAS 616-91-1) Sales by Application (2023-2028) & (MT)
Table 94. Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2022) & (MT)
Table 97. Latin America N-acetylcysteine(CAS 616-91-1) Sales by Country (2023-2028) & (MT)
Table 98. Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America N-acetylcysteine(CAS 616-91-1) Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Type (2017-2022) & (MT)
Table 101. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Type (2023-2028) & (MT)
Table 102. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Application (2017-2022) & (MT)
Table 105. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Application (2023-2028) & (MT)
Table 106. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Country (2017-2022) & (MT)
Table 109. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales by Country (2023-2028) & (MT)
Table 110. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue by Country (2023-2028) & (US$ Million)
Table 112. BASF Corporation Information
Table 113. BASF Description and Major Businesses
Table 114. BASF N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. BASF N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. BASF Recent Development
Table 117. WACKER Corporation Information
Table 118. WACKER Description and Major Businesses
Table 119. WACKER N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. WACKER N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. WACKER Recent Development
Table 122. Cumberland Pharmaceuticals Corporation Information
Table 123. Cumberland Pharmaceuticals Description and Major Businesses
Table 124. Cumberland Pharmaceuticals N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Cumberland Pharmaceuticals N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Cumberland Pharmaceuticals Recent Development
Table 127. Zambon Corporation Information
Table 128. Zambon Description and Major Businesses
Table 129. Zambon N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Zambon N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zambon Recent Development
Table 132. Bioniche Life Sciences Corporation Information
Table 133. Bioniche Life Sciences Description and Major Businesses
Table 134. Bioniche Life Sciences N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Bioniche Life Sciences N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bioniche Life Sciences Recent Development
Table 137. Manus Aktteva Biopharma Corporation Information
Table 138. Manus Aktteva Biopharma Description and Major Businesses
Table 139. Manus Aktteva Biopharma N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Manus Aktteva Biopharma N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Manus Aktteva Biopharma Recent Development
Table 142. Hubei Shengbaolai Biological Technology Corporation Information
Table 143. Hubei Shengbaolai Biological Technology Description and Major Businesses
Table 144. Hubei Shengbaolai Biological Technology N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Hubei Shengbaolai Biological Technology N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hubei Shengbaolai Biological Technology Recent Development
Table 147. Ningbo Create-BIO ENGINEERING Corporation Information
Table 148. Ningbo Create-BIO ENGINEERING Description and Major Businesses
Table 149. Ningbo Create-BIO ENGINEERING N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 150. Ningbo Create-BIO ENGINEERING N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Ningbo Create-BIO ENGINEERING Recent Development
Table 152. XYS Corporation Information
Table 153. XYS Description and Major Businesses
Table 154. XYS N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 155. XYS N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. XYS Recent Development
Table 157. Hubei Jusheng Technology Corporation Information
Table 158. Hubei Jusheng Technology Description and Major Businesses
Table 159. Hubei Jusheng Technology N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 160. Hubei Jusheng Technology N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hubei Jusheng Technology Recent Development
Table 162. Wuhan Grand Hoyo Corporation Information
Table 163. Wuhan Grand Hoyo Description and Major Businesses
Table 164. Wuhan Grand Hoyo N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 165. Wuhan Grand Hoyo N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Wuhan Grand Hoyo Recent Development
Table 167. Wuhan Hezhong Bio-Chemical Corporation Information
Table 168. Wuhan Hezhong Bio-Chemical Description and Major Businesses
Table 169. Wuhan Hezhong Bio-Chemical N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 170. Wuhan Hezhong Bio-Chemical N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Wuhan Hezhong Bio-Chemical Recent Development
Table 172. Zhangjiagang Huachang Pharmaceutical Corporation Information
Table 173. Zhangjiagang Huachang Pharmaceutical Description and Major Businesses
Table 174. Zhangjiagang Huachang Pharmaceutical N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 175. Zhangjiagang Huachang Pharmaceutical N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Zhangjiagang Huachang Pharmaceutical Recent Development
Table 177. Zhangjiagang Shuguang Biological Factory Corporation Information
Table 178. Zhangjiagang Shuguang Biological Factory Description and Major Businesses
Table 179. Zhangjiagang Shuguang Biological Factory N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 180. Zhangjiagang Shuguang Biological Factory N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Zhangjiagang Shuguang Biological Factory Recent Development
Table 182. Donboo Amino Acid Corporation Information
Table 183. Donboo Amino Acid Description and Major Businesses
Table 184. Donboo Amino Acid N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 185. Donboo Amino Acid N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Donboo Amino Acid Recent Development
Table 187. WUXI ENOVO CHEMICAL Corporation Information
Table 188. WUXI ENOVO CHEMICAL Description and Major Businesses
Table 189. WUXI ENOVO CHEMICAL N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 190. WUXI ENOVO CHEMICAL N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. WUXI ENOVO CHEMICAL Recent Development
Table 192. Ningbo Zhenhai Haide Amino Acid Corporation Information
Table 193. Ningbo Zhenhai Haide Amino Acid Description and Major Businesses
Table 194. Ningbo Zhenhai Haide Amino Acid N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 195. Ningbo Zhenhai Haide Amino Acid N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Ningbo Zhenhai Haide Amino Acid Recent Development
Table 197. Xinyi Hanling Biological Engineering Corporation Information
Table 198. Xinyi Hanling Biological Engineering Description and Major Businesses
Table 199. Xinyi Hanling Biological Engineering N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 200. Xinyi Hanling Biological Engineering N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Xinyi Hanling Biological Engineering Recent Development
Table 202. ZHANGJIAGANG SPECOM BIOCHEMICAL Corporation Information
Table 203. ZHANGJIAGANG SPECOM BIOCHEMICAL Description and Major Businesses
Table 204. ZHANGJIAGANG SPECOM BIOCHEMICAL N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 205. ZHANGJIAGANG SPECOM BIOCHEMICAL N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. ZHANGJIAGANG SPECOM BIOCHEMICAL Recent Development
Table 207. Wuhan lullaby pharmaceutical chemical Corporation Information
Table 208. Wuhan lullaby pharmaceutical chemical Description and Major Businesses
Table 209. Wuhan lullaby pharmaceutical chemical N-acetylcysteine(CAS 616-91-1) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 210. Wuhan lullaby pharmaceutical chemical N-acetylcysteine(CAS 616-91-1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Wuhan lullaby pharmaceutical chemical Recent Development
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. N-acetylcysteine(CAS 616-91-1) Distributors List
Table 215. N-acetylcysteine(CAS 616-91-1) Customers List
Table 216. N-acetylcysteine(CAS 616-91-1) Market Trends
Table 217. N-acetylcysteine(CAS 616-91-1) Market Drivers
Table 218. N-acetylcysteine(CAS 616-91-1) Market Challenges
Table 219. N-acetylcysteine(CAS 616-91-1) Market Restraints
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. N-acetylcysteine(CAS 616-91-1) Product Picture
Figure 2. Global N-acetylcysteine(CAS 616-91-1) Market Share by Type in 2021 & 2028
Figure 3. Medical Grade N-acetylcysteine Product Picture
Figure 4. Industrial Grade N-acetylcysteine Product Picture
Figure 5. Global N-acetylcysteine(CAS 616-91-1) Market Share by Application in 2021 & 2028
Figure 6. Paracetamol Overdose
Figure 7. Mucolytic Therapy
Figure 8. Nephroprotective Agent
Figure 9. Cyclophosphamide-induced Hemorrhagic Cystitis
Figure 10. Microbiological
Figure 11. Interstitial Lung Disease
Figure 12. Psychiatry
Figure 13. N-acetylcysteine(CAS 616-91-1) Report Years Considered
Figure 14. Global N-acetylcysteine(CAS 616-91-1) Capacity, Production and Utilization (2017-2028) & (MT)
Figure 15. Global N-acetylcysteine(CAS 616-91-1) Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global N-acetylcysteine(CAS 616-91-1) Production Market Share by Region (2017-2022)
Figure 17. Global N-acetylcysteine(CAS 616-91-1) Production Market Share by Region (2023-2028)
Figure 18. N-acetylcysteine(CAS 616-91-1) Production Growth Rate in North America (2017-2028) & (MT)
Figure 19. N-acetylcysteine(CAS 616-91-1) Production Growth Rate in Europe (2017-2028) & (MT)
Figure 20. N-acetylcysteine(CAS 616-91-1) Production Growth Rate in China (2017-2028) & (MT)
Figure 21. N-acetylcysteine(CAS 616-91-1) Production Growth Rate in Japan (2017-2028) & (MT)
Figure 22. Global N-acetylcysteine(CAS 616-91-1) Sales 2017-2028 (MT)
Figure 23. Global N-acetylcysteine(CAS 616-91-1) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 24. Global N-acetylcysteine(CAS 616-91-1) Revenue 2017-2028 (US$ Million)
Figure 25. Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 26. Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Region (2017-2022)
Figure 27. Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Region (2023-2028)
Figure 28. North America N-acetylcysteine(CAS 616-91-1) Sales YoY (2017-2028) & (MT)
Figure 29. North America N-acetylcysteine(CAS 616-91-1) Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Europe N-acetylcysteine(CAS 616-91-1) Sales YoY (2017-2028) & (MT)
Figure 31. Europe N-acetylcysteine(CAS 616-91-1) Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific N-acetylcysteine(CAS 616-91-1) Sales YoY (2017-2028) & (MT)
Figure 33. Asia-Pacific N-acetylcysteine(CAS 616-91-1) Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Latin America N-acetylcysteine(CAS 616-91-1) Sales YoY (2017-2028) & (MT)
Figure 35. Latin America N-acetylcysteine(CAS 616-91-1) Revenue YoY (2017-2028) & (US$ Million)
Figure 36. Middle East & Africa N-acetylcysteine(CAS 616-91-1) Sales YoY (2017-2028) & (MT)
Figure 37. Middle East & Africa N-acetylcysteine(CAS 616-91-1) Revenue YoY (2017-2028) & (US$ Million)
Figure 38. The N-acetylcysteine(CAS 616-91-1) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 39. The Top 5 and 10 Largest Manufacturers of N-acetylcysteine(CAS 616-91-1) in the World: Market Share by N-acetylcysteine(CAS 616-91-1) Revenue in 2021
Figure 40. N-acetylcysteine(CAS 616-91-1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 41. Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Type (2017-2028)
Figure 42. Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Type (2017-2028)
Figure 43. Global N-acetylcysteine(CAS 616-91-1) Sales Market Share by Application (2017-2028)
Figure 44. Global N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Application (2017-2028)
Figure 45. North America N-acetylcysteine(CAS 616-91-1) Sales Market Share by Type (2017-2028)
Figure 46. North America N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Type (2017-2028)
Figure 47. North America N-acetylcysteine(CAS 616-91-1) Sales Market Share by Application (2017-2028)
Figure 48. North America N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Application (2017-2028)
Figure 49. North America N-acetylcysteine(CAS 616-91-1) Sales Share by Country (2017-2028)
Figure 50. North America N-acetylcysteine(CAS 616-91-1) Revenue Share by Country (2017-2028)
Figure 51. U.S. N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 52. Canada N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 53. Europe N-acetylcysteine(CAS 616-91-1) Sales Market Share by Type (2017-2028)
Figure 54. Europe N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Type (2017-2028)
Figure 55. Europe N-acetylcysteine(CAS 616-91-1) Sales Market Share by Application (2017-2028)
Figure 56. Europe N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Application (2017-2028)
Figure 57. Europe N-acetylcysteine(CAS 616-91-1) Sales Share by Country (2017-2028)
Figure 58. Europe N-acetylcysteine(CAS 616-91-1) Revenue Share by Country (2017-2028)
Figure 59. Germany N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 60. France N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 61. U.K. N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 62. Italy N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 63. Russia N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 64. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales Market Share by Type (2017-2028)
Figure 65. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Type (2017-2028)
Figure 66. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales Market Share by Application (2017-2028)
Figure 67. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Application (2017-2028)
Figure 68. Asia Pacific N-acetylcysteine(CAS 616-91-1) Sales Share by Region (2017-2028)
Figure 69. Asia Pacific N-acetylcysteine(CAS 616-91-1) Revenue Share by Region (2017-2028)
Figure 70. China N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 71. Japan N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 72. South Korea N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 73. India N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 74. Australia N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 75. Taiwan N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 76. Indonesia N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 77. Thailand N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 78. Malaysia N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 79. Philippines N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 80. Latin America N-acetylcysteine(CAS 616-91-1) Sales Market Share by Type (2017-2028)
Figure 81. Latin America N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Type (2017-2028)
Figure 82. Latin America N-acetylcysteine(CAS 616-91-1) Sales Market Share by Application (2017-2028)
Figure 83. Latin America N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Application (2017-2028)
Figure 84. Latin America N-acetylcysteine(CAS 616-91-1) Sales Share by Country (2017-2028)
Figure 85. Latin America N-acetylcysteine(CAS 616-91-1) Revenue Share by Country (2017-2028)
Figure 86. Mexico N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 87. Brazil N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 88. Argentina N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 89. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales Market Share by Type (2017-2028)
Figure 90. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Type (2017-2028)
Figure 91. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales Market Share by Application (2017-2028)
Figure 92. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue Market Share by Application (2017-2028)
Figure 93. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Sales Share by Country (2017-2028)
Figure 94. Middle East and Africa N-acetylcysteine(CAS 616-91-1) Revenue Share by Country (2017-2028)
Figure 95. Turkey N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 96. Saudi Arabia N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 97. U.A.E N-acetylcysteine(CAS 616-91-1) Revenue (2017-2028) & (US$ Million)
Figure 98. N-acetylcysteine(CAS 616-91-1) Value Chain
Figure 99. N-acetylcysteine(CAS 616-91-1) Production Process
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Bottom-up and Top-down Approaches for This Report
Figure 103. Data Triangulation
Figure 104. Key Executives Interviewed

---